Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
Orhan Kerim İnci(Izmir Institute of Technology), Volkan Seyrantepe(Izmir Institute of Technology), Melike Can(Izmir Institute of Technology), Hande Basırlı(Izmir Institute of Technology), Selman Yanbul(Izmir Institute of Technology)
Cited by 11
Related Papers
Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells
|Journal of Biological Chemistry|2004|145
Regulation of Phagocytosis in Macrophages by Neuraminidase 1
|Journal of Biological Chemistry|2009|96
Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease
|Experimental Neurology|2017|82
GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
|Journal of Neuroinflammation|2020|65
Sialidase neu4 deficiency is associated with neuroinflammation in mice
|Glycoconjugate Journal|2021|8